Collaborations for advanced diagnostics, including the application of artificial intelligence to track structural heart disease, lead the list of collaborations announced by the medical device industry during the last two months of 2018, as tracked by Strategic Transactions.
In December, Amarantus BioScience Holdings Inc. and Todos Medical Ltd. agreed to form a joint venture called Breakthrough Diagnostics Inc., to develop LymPro Test 2.0, a blood...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?